BioNxt Solutions Statistics
Total Valuation
CSE:BNXT has a market cap or net worth of CAD 67.59 million. The enterprise value is 73.12 million.
Market Cap | 67.59M |
Enterprise Value | 73.12M |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
Earnings Date | Aug 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:BNXT has 116.53 million shares outstanding. The number of shares has increased by 9.53% in one year.
Current Share Class | 116.53M |
Shares Outstanding | 116.53M |
Shares Change (YoY) | +9.53% |
Shares Change (QoQ) | +1.75% |
Owned by Insiders (%) | 5.86% |
Owned by Institutions (%) | n/a |
Float | 110.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,958.06 |
PB Ratio | -8.94 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -12.80 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
Current Ratio | 0.15 |
Quick Ratio | 0.11 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.87 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -342.44% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 145.24% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -89,790 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.29% in the last 52 weeks. The beta is 1.58, so CSE:BNXT's price volatility has been higher than the market average.
Beta (5Y) | 1.58 |
52-Week Price Change | +89.29% |
50-Day Moving Average | 0.51 |
200-Day Moving Average | 0.40 |
Relative Strength Index (RSI) | 48.69 |
Average Volume (20 Days) | 59,897 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:BNXT had revenue of CAD 22,849 and -5.71 million in losses. Loss per share was -0.06.
Revenue | 22,849 |
Gross Profit | 22,849 |
Operating Income | -4.95M |
Pretax Income | -5.80M |
Net Income | -5.71M |
EBITDA | -4.85M |
EBIT | -4.95M |
Loss Per Share | -0.06 |
Balance Sheet
The company has 329,138 in cash and 6.68 million in debt, giving a net cash position of -6.35 million or -0.05 per share.
Cash & Cash Equivalents | 329,138 |
Total Debt | 6.68M |
Net Cash | -6.35M |
Net Cash Per Share | -0.05 |
Equity (Book Value) | -7.56M |
Book Value Per Share | -0.07 |
Working Capital | -3.74M |
Cash Flow
Operating Cash Flow | -3.36M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -21,642.87% |
Pretax Margin | -25,392.86% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:BNXT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.53% |
Shareholder Yield | n/a |
Earnings Yield | -8.45% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |